Robert Schafer
Lakewood
Summary
Scientific professional with comprehensive background in laboratory techniques and methodologies. Known for exceptional accuracy and reliability in conducting tests and experiments. Prioritizes team collaboration and adapts seamlessly to dynamic environments. Proficient in data analysis and laboratory safety protocols, valued for meticulous attention to detail and strong problem-solving abilities.
Overview
14
14
years of professional experience
Work History
Laboratory Technician II
Phoenix Children’s Hospital
Phoenix, Az
01.2016 - Current
- Coordinated and managed laboratory projects and experiments.
- Conducted routine laboratory tests to ensure accurate results for patient care.
- Operated and maintained laboratory equipment to uphold quality standards.
- Analyzed data using analytical softwares and created reports.
- Interpreted laboratory results to provide technical advice to scientists.
Quality Control Technician
AZPACK Company
Tempe, Az
01.2013 - 01.2015
- Analyzed test results and documented findings to identify areas for process improvement and risk mitigation.
- Tested and evaluated product precision against specifications to reduce discrepancies.
- Performed routine maintenance and calibration on testing equipment.
- Implemented corrective actions for non-conforming products, enhancing overall production efficiency.
Education
Bachelor of Science - Neurobiology, Anthropology
Arizona State University
Tempe, Az01-2021
Associates in Science - Science
Mesa Community College
Mesa, Az01-2015
Skills
- Microbiology, histology; DNA/RNA purification; molecular cloning; PCR; mammalian cell culture; induced pluripotent stem cell culture; iPSC organoid differentiation; tissue staining; microscopy; protein purification; western blotting;
Timeline
Laboratory Technician II
Phoenix Children’s Hospital
01.2016 - Current
Quality Control Technician
AZPACK Company
01.2013 - 01.2015
Associates in Science - Science
Mesa Community College
Bachelor of Science - Neurobiology, Anthropology
Arizona State University
Presentations/Publications
- 2025 “Antisense Oligonucleotide treatment for rare pediatric movement disorders”. University of Arizona Works in Progress seminar series.
- 2020 “Validation of KANK1 gene variants in cerebral palsy patients: Potential effects on cellular phenotypes,” Barrow Neurological Institute Grand Rounds.
- 2019 “Preliminary data supports the hypothesis that mutations in KANK1 alter cellular phenotypes,” International Cerebral Palsy Genomics Consortium.
- 2019 “Preliminary data supports the hypothesis that mutations in KANK1 alter cellular phenotypes,” Reimagine Health at University of Arizona college of Medicine.
- 2015 “Organization of mouse cortical neuronal ultrastructure using transmission electron microscopy”. Arizona Imaging & Microanalysis Society meeting.
- Sandra M Nordlie, Robert Schafer, Adam Rauckhorst , Ana M Santos-Exposito , Andres Prieto-Rodriguez, Bryce A Wilson , Idil A Evans , Una Hadziametovic , Frances Nowlen, Carlos Santos-Ocaña, Eric B Taylor , Michael C Kruer, Sergio Padilla-Lopez. PANK2-mediated de novo CoA synthesis is required for metabolic switching to fatty acid oxidation. In preparation for Cell Reports.
- Guida BS, Lewis SA, Heier C, Bakhtiari S, Lennart, Kruer TN, Shetty S, Schafer R, Zimmerman R, Padilla-Lopez S, Santos-Ocana C, Kruer MC. Compound heterozygous mutations in PNPLA7 lead to intellectual disability and cerebral palsy. In preparation for Human Molecular Genetics.
- Sara A. Lewis, Jacob Forstrom, Jennifer Tavani, Robert Schafer, Zach Tiede, Sergio R. Padilla-Lopez, Michael C. Kruer. eIF2α phosphorylation evokes dystonia-like movements with D2-receptor and cholinergic origin and abnormal neuronal connectivity. In preparation for Movement Disorders.